We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

British & American Investment Trust plc (BAF) Ordinary Shares GBP1

Sell:23.00p Buy:29.00p 0 Change: No change
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:23.00p
Buy:29.00p
Change: No change
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:23.00p
Buy:29.00p
Change: No change
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

The policy is to invest predominantly in investment trusts and other leading UK and US-quoted companies to achieve a balance of income and growth.
Security Weight
Lineage Cell Therapeutics Inc 27.13%
Dunedin Inc Growth Investment Trust Ord 25p 14.26%
Geron Corp 10.09%
Aberdeen Diversified Income And Growth Ord 6.60%
Relief Therapeutics (Switzerland) 1.06%
Agex (Usa) 1.03%
Audioboom Group plc ORD NPV 0.81%
ADVFN plc Ordinary Shares 0.2p 0.72%
Braemar Shipping Services plc Ordinary 10p 0.72%
Electra Private Equity 0.71%
Sector Weight
Healthcare 37.36%
Financial Services 15.10%
Communication Services 0.87%
Industrials 0.86%
Technology 0.14%
Consumer Cyclical 0.07%
Real Estate 0.06%
Utilities 0.06%
Consumer Defensive 0.04%
Basic Materials 0.03%
Country Weight
United States 38.48%
United Kingdom 16.14%
Ireland 0.17%
Cayman Islands 0.11%
Mexico 0.09%
Indonesia 0.08%
Brazil 0.07%
South Africa 0.06%
Colombia 0.05%
Luxembourg 0.05%

Fee Structure

The Trust is internally managed. The Managing Director has an employment contract with the Company terminable on notice period of 12 months.

Dividend Policy

Due to the unprecedented disruption caused to markets by the Covid-19 pandemic in 2020 and the severe decline in dividends paid by companies last year, we do not recommend the payment of a final dividend for the 2020 financial year. It is our intention to resume our normal dividend payments as soon as possible, as and when circumstances permit. We will also endeavour, through ad hoc interim payments not necessarily on our normal dividend timetable, to catch up when and if possible on withheld or reduced payments.

ASSET SPLIT

Total number of holdings: 14.

Trust Manager

Jonathan Woolf

Manager Bio

Not currently available for this investment trust.

Board Of Directors

David SeligmanChairman, Jonathan Woolf, Julia Le Blan, Alex Tamlyn

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.